Stanford University

Total Awards: 
89
Award Value: 
$297,351,008
Major Facility Name: 
Lorry I. Lokey Stem Cell Research Building
Institution type: 
Not for profit

Awards to the Institution

Award Value
Disease Team Research I: Irving Weissman Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
Tools and Technologies II: Marius Wernig Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
New Faculty I: Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
New Faculty Physician Scientist: Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,536
Research Training II: Theo Palmer CIRM Training Program $7,475,333
Tools and Technologies II: Irving Weissman Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,881
Tools and Technologies II: Brian Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Tools and Technologies II: Sarah Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
Tools and Technologies II: Theo Palmer Development of small molecule screens for autism using patient-derived iPS cells $1,797,981
Tools and Technologies II: Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
New Faculty I: Joanna Wysocka Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,374,020
New Faculty I: Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
New Faculty I: Howard Chang Noncoding RNAs in Cell Fate Determination $2,985,894
Disease Team Therapy Development - Research: Joseph Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,942,877
Early Translational III: Bertha Chen Autologous iPSC Therapy for Urinary Incontinence $5,025,428
Tissue Collection for Disease Modeling: Joseph Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,834
Disease Team Therapy Development III: Irving Weissman Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $7,672,364
Research Leadership 12: Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $5,436,307
Genomics Centers of Excellence Awards (R): Michael Snyder Center of Excellence for Stem Cell Genomics $22,831,963
Basic Biology V: Marius Wernig Mechanisms of human induced neuronal cell reprogramming $1,178,370
Basic Biology V: Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
Early Translational III: Joseph Wu Heart Repair with Human Tissue Engineered Myocardium $4,397,241
Basic Biology V: Helen Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
Disease Team Therapy Planning I: Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
Training Grant I-1: Michael Longaker Stanford CIRM Training Program $3,035,282
Early Translational III: Helen Blau Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,920
Disease Team Therapy Development - Research: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $19,068,382
Disease Team Therapy Planning I: Albert Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Disease Team Therapy Planning I: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
Disease Team Planning: Robert Robbins {REDACTED} Cardiovascular Regenerative Team $25,119
Creativity Awards: Paul Utz [REDACTED] Program: Stem Cell & Developmental Biology Research Internships $273,201
Tools and Technologies I: Helen Blau Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Tissue Collection for Disease Modeling: Joachim Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
Disease Team Planning: Thomas Rando Stem Cell Therapy for Muscular Dystrophy $0
Early Translational IV: Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
Major Facilities: John Hennessy Stanford SIM1 Building $43,578,000
Basic Biology V: Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Total:
$190,860,898.00

Pages

Icon for xls export

© 2013 California Institute for Regenerative Medicine